Answer:
The name of the product is Exubera and be developed as a collaboration between Aventis (before being purchased by Sanofi) and Pfizer. There have been some recent litigation brought by Novo-nordisk that threatened to scuttle the launch of the product but the launch is presently underway. You should ask your doctor nearly this product as a supplement or replacement to your current insulin therapy.

---

http://www.diabetesmonitor.com/inhaledi....
here ya go

---

they are doing a study beside this.... a friend of mine is on the study.... there are breathing side effects he is experiencing, but his blood sugar is contained by a good length.... hope this works!

---

The inhaler is avaliable to adults over 18, but is still at early stages and apparantly difficult to use.

---